Split T-cell tolerance as a guide for the development of tumor antigen-specific immunotherapy.

about

Measurement of serum antibodies against NY-ESO-1 by ELISA: A guide for the treatment of specific immunotherapy for patients with advanced colorectal cancer.

P2860

Q34119630-376926A9-445C-4700-ABDF-C57C0B7F7F7B

P2860

Split T-cell tolerance as a guide for the development of tumor antigen-specific immunotherapy.

Item

http://www.wikidata.org/entity/Q42214135

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Split T-cell tolerance as a gu ...... ntigen-specific immunotherapy.

@en

Split T-cell tolerance as a gu ...... ntigen-specific immunotherapy.

@nl

type

Item

label

Split T-cell tolerance as a gu ...... ntigen-specific immunotherapy.

@en

Split T-cell tolerance as a gu ...... ntigen-specific immunotherapy.

@nl

prefLabel

Split T-cell tolerance as a gu ...... ntigen-specific immunotherapy.

@en

Split T-cell tolerance as a gu ...... ntigen-specific immunotherapy.

@nl

P1476

Split T-cell tolerance as a gu ...... ntigen-specific immunotherapy.

@en

P2093

Sacha Gnjatic

http://www.w3.org/2001/XMLSchema#string

Takemasa Tsuji

http://www.w3.org/2001/XMLSchema#string

P2860

Split T cell tolerance against a self/tumor antigen: spontaneous CD4+ but not CD8+ T cell responses against p53 in cancer patients and healthy donors.

NY-ESO-1: review of an immunogenic tumor antigen.

Integrated NY-ESO-1 antibody and CD8+ T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab

Tolerance to p53 by A2.1-restricted cytotoxic T lymphocytes.

Medullary epithelial cells of the human thymus express a highly diverse selection of tissue-specific genes colocalized in chromosomal clusters.

Ectopic expression of peripheral-tissue antigens in the thymic epithelium: probabilistic, monoallelic, misinitiated

Minimal tolerance to a tumor antigen encoded by a cancer-germline gene.

NY-CO-58/KIF2C is overexpressed in a variety of solid tumors and induces frequent T cell responses in patients with colorectal cancer.

P304

405-407

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4161/ONCI.19310

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

228072438

http://www.w3.org/2001/XMLSchema#string

P698

22737632

http://www.w3.org/2001/XMLSchema#string

P921

immunotherapy

P932

3382850

http://www.w3.org/2001/XMLSchema#string

Split T-cell tolerance as a guide for the development of tumor antigen-specific immunotherapy.

about

P2860

P2860

Split T-cell tolerance as a guide for the development of tumor antigen-specific immunotherapy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P932